Genetic Sucrase-Isomaltase Deficiency (GSID), also known as Congenital Sucrase-Isomaltase Deficiency (CSID), is a disorder that causes a reduction of the enzyme activity needed to break down and absorb table sugar (sucrose) and other sugars from starch.
Sucraid® (sacrosidase) Oral Solution is the only FDA-approved enzyme replacement therapy that facilitates breakdown of sucrose (sugar) into simpler forms for absorption from the intestine into the blood. Sucraid® is available in 118 mL translucent plastic bottles, packaged two bottles per box. Sucraid® is usually taken with each meal or snack, mixed into 2-4 ounces of water, milk or infant formula.
Click the How to Order tab above to download a Sucraid®
Patient Enrollment Form or call 1-800-705-1962. Sucraid® is only available through an exclusive specialty pharmacy provider that ships therapy directly to the patient's home or physician's office.
The SucraidASSIST™ program provides patients with access to a variety of support services, including insurance assessment, financial assistance, pharmacy services, peer support coaching, and nutrition counseling.